Schinkel A, Mayer U, Wagenaar E, Mol C, van Deemter L, Smit J
Proc Natl Acad Sci U S A. 1997; 94(8):4028-33.
PMID: 9108099
PMC: 20562.
DOI: 10.1073/pnas.94.8.4028.
Wiltrout R, Mathieson B, Talmadge J, Reynolds C, Zhang S, Herberman R
J Exp Med. 1984; 160(5):1431-49.
PMID: 6491601
PMC: 2187504.
DOI: 10.1084/jem.160.5.1431.
Lagarde A
Cancer Metastasis Rev. 1984; 3(2):143-69.
PMID: 6386143
DOI: 10.1007/BF00047661.
Biron C, Habu S, Okumura K, Welsh R
J Virol. 1984; 50(3):698-707.
PMID: 6374165
PMC: 255727.
DOI: 10.1128/JVI.50.3.698-707.1984.
Ghiara P, Boraschi D, Villa L, Scapigliati G, Taddei C, Tagliabue A
Immunology. 1985; 55(2):317-24.
PMID: 3924820
PMC: 1453603.
Interleukin 3 promotes erythroid burst formation in "serum-free" cultures without detectable erythropoietin.
Goodman J, Hall E, Miller K, Shinpock S
Proc Natl Acad Sci U S A. 1985; 82(10):3291-5.
PMID: 3923475
PMC: 397761.
DOI: 10.1073/pnas.82.10.3291.
Dietary fatty acid effects on T-cell-mediated immunity in mice infected with mycoplasma pulmonis or given carcinogens by injection.
Bennett M, Uauy R, Grundy S
Am J Pathol. 1987; 126(1):103-13.
PMID: 3812635
PMC: 1899541.
Origin and differentiation of natural killer cells. III. Relationship between the precursors and effectors of natural killer and natural cytotoxic activity.
Hackett Jr J, Bennett M, Koo G, Kumar V
Immunol Res. 1986; 5(1):16-24.
PMID: 3760639
DOI: 10.1007/BF02917190.
Surface phenotypes of human peripheral blood mononuclear cells from patients with gastrointestinal carcinoma.
Boltz G, Penner E, Holzinger C, Bakos S, Fellinger A, Walgram M
J Cancer Res Clin Oncol. 1987; 113(3):291-7.
PMID: 3584219
DOI: 10.1007/BF00396388.
Natural killer cell and islet killer cell activities in type 1 (insulin-dependent) diabetes.
Negishi K, Waldeck N, Chandy G, Buckingham B, Kershnar A, Fisher L
Diabetologia. 1986; 29(6):352-7.
PMID: 3527835
DOI: 10.1007/BF00903343.
Increased lymphokine activated killer (LAK) activity in the regional lymph nodes of mice following immunization with contact sensitizing agents.
Gao L, Asherson G, Malkovsky M
Clin Exp Immunol. 1987; 70(1):217-21.
PMID: 3500814
PMC: 1542224.
Natural cytotoxic (NC) activity: a multi-lineage system regulated by IL-2.
Lattime E, Bykowsky M, Stutman O
Immunol Res. 1986; 5(1):5-15.
PMID: 3489796
DOI: 10.1007/BF02917189.
Activation and proliferation of normal resting human T lymphocytes in serum-free culture: role of IL-4 and IL-6.
Habetswallner D, Pelosi E, Bulgarini D, Camagna A, Samoggia P, Montesoro E
Immunology. 1988; 65(3):357-64.
PMID: 3264807
PMC: 1385472.
Heterogeneous cytotoxic cells that kill NC-sensitive WEHI-164 tumor cells are activated in allogeneic mixed lymphocyte reactions.
Macphail S, Stutman O
Immunol Res. 1986; 5(1):40-9.
PMID: 2944973
DOI: 10.1007/BF02917193.
Membrane markers, target cell specificity, and sensitivity to biological response modifiers distinguish human natural cytotoxic from human natural killer cells.
Rola-Pleszczynski M, Lieu H, Sullivan A, Girard M
J Clin Invest. 1985; 76(5):1927-31.
PMID: 2932473
PMC: 424244.
DOI: 10.1172/JCI112189.
Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities.
Nair M, Lewis E, Schwartz S
J Clin Immunol. 1986; 6(5):363-72.
PMID: 2429979
DOI: 10.1007/BF00915375.
Contrasting effects of RNA and protein synthesis blocking on natural and lectin-dependent cell-mediated cytotoxicity against adherent HEp-2 cells.
Perl A, Falucskai L, Gergely P, Feher J
Experientia. 1985; 41(10):1344-6.
PMID: 2412880
DOI: 10.1007/BF01952087.
Antitumor immune surveillance by tumor necrosis factor producing cells.
Lattime E, Stutman O
Immunol Res. 1991; 10(2):104-13.
PMID: 1919168
DOI: 10.1007/BF02918158.